Cita APA

Pawlyn, C., Bright, M. D., Buros, A. F., Stein, C. K., Walters, Z., Aronson, L. I., . . . Davies, F. E. (2017). Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control. Blood Cancer J.

Citación estilo Chicago

Pawlyn, C., et al. "Overexpression of EZH2 in Multiple Myeloma Is Associated With Poor Prognosis and Dysregulation of Cell Cycle Control." Blood Cancer J 2017.

Cita MLA

Pawlyn, C., et al. "Overexpression of EZH2 in Multiple Myeloma Is Associated With Poor Prognosis and Dysregulation of Cell Cycle Control." Blood Cancer J 2017.